State Street SPDR S&P Biotech ETF (Derivatives) Price (XBI) Real-time Market Overview
Last Updated:Jul 29, 2026 4:04 a.m. (UTC)
How Much Is 1 State Street SPDR S&P Biotech ETF (Derivatives) (XBI) Worth in USD?
The current spot value of 1 XBI is $154.54 USD. For a practical spending reference, a standard amount of $10.00 buys exactly 0.0647 XBI at this live rate. Within the last 24-hour trading session, the price moved within a defined market corridor, hitting a low of $0 and peaking at $0USD
What are the State Street SPDR S&P Biotech ETF (Derivatives)(XBI) Price Details
The current real-time price of XBI is $154.54 on OneBullEx, tracking an active 24-hour range between $0 and $0. For users navigating their financial growth—from compounding initial rewards to managing advanced multi-asset portfolios—this momentum delivers a clear multi-timeframe breakdown of +0.16% (1h), +1.36% (24h), and -2.77% (7d). As you benchmark these cycles against XBI’s all-time high of $-- and all-time low of $--, these live metrics serve as a sub-second compass for your next strategic move on OneBullEx Exchange.
Future price trend of XBI
What is the price prediction for XBI in 2027?
If you are wondering how high State Street SPDR S&P Biotech ETF (Derivatives) (XBI) can go, our 2027 price forecast projects it to potentially hit $170.38 . This represents a steady +10.25% increase from its current level, assuming a stable growth trend. Curious about the long-term outlook? Check out our comprehensive State Street SPDR S&P Biotech ETF (Derivatives) price predictions for 2026, 2027, and 2030-2050.
Is it too late to buy State Street SPDR S&P Biotech ETF (Derivatives) (XBI) for 2029?
It's not too late. Based on a conservative +5% annual growth rate forecast from its current price, State Street SPDR S&P Biotech ETF (Derivatives) (XBI) is realistically expected to reach $187.84 by 2029. This means holding the asset from today's level until the end of 2029 can still deliver a steady cumulative ROI of +21.55%. For a complete strategic breakdown, see our long-term State Street SPDR S&P Biotech ETF (Derivatives) price predictions for 2026, 2027, and 2029-2050.
Where Can I Buy State Street SPDR S&P Biotech ETF (Derivatives) (XBI) ?
Start Trading on the OneBullEx App
Trade on OneBullEx
Deposit your cryptocurrencies to OneBullEx and enjoy institutional-grade liquidity, zero-coping-hassle AI strategies, and low trading fees.
TradeFrequently Asked Questions About State Street SPDR S&P Biotech ETF (Derivatives) (XBI)
Is it a safe time to buy State Street SPDR S&P Biotech ETF (Derivatives) (XBI) right now, or is the market overbought?
As of 2026-07-29 04:04 UTC, State Street SPDR S&P Biotech ETF (Derivatives) is trading at $154.54 with a 24-hour change of +1.36% ($2.08). Currently, the market sentiment is sits at a 29 (Fear) index level. When sentiment enters this zone, short-term retail trading becomes highly emotional. Always cross-reference the sentiment with current volume to avoid catching a local top.
Why is State Street SPDR S&P Biotech ETF (Derivatives) moving so violently today? What is its intraday volatility range?
Today's price action for State Street SPDR S&P Biotech ETF (Derivatives) shows a 24-hour amplitude of 0.00%. According to the position bar, the current price is sitting at the -- mark of its daily range. A high position bar combined with an expanding daily amplitude indicates aggressive bidding by buyers, pushing the asset into the day's high-intensity volatility zone.
How do I determine the short-term strength and momentum of State Street SPDR S&P Biotech ETF (Derivatives)?
To gauge the immediate trend, look at the gap between the short-term and medium-term moving averages: MA7 ($--) and MA30 ($--) are currently separated by 0.00%. When this gap expands alongside a positive 24H net institutional inflow of N/A, it confirms that smart money is actively driving the trend rather than retail speculation.
Is there a risk of a sudden flash crash or a short squeeze for State Street SPDR S&P Biotech ETF (Derivatives) (XBI)?
The derivatives market for State Street SPDR S&P Biotech ETF (Derivatives) currently holds an Open Interest (OI) of $7.22M, with the funding rate hovering at -0.01%. When open interest spikes sharply while the funding rate becomes highly positive, it indicates an overcrowded long leverage. This market structure signals an increased risk of a sudden 'long squeeze' or violent liquidation cascades.
What is the Fully Diluted Valuation (FDV) of State Street SPDR S&P Biotech ETF (Derivatives), and how much supply is circulating?
State Street SPDR S&P Biotech ETF (Derivatives) currently has a circulating supply rate of --, giving it a live Market Cap of $0.00. Its Fully Diluted Valuation (FDV) stands at $--, leading to an FDV-to-Market-Cap ratio of 0.00. A higher ratio implies that a significant amount of tokens are locked and waiting to be unlocked, which long-term holders should monitor for potential future supply inflation.
Risk Disclaimer
Cryptocurrency investments are subject to high market risk. Past performance is not a guarantee of future results. OneBullEx is not responsible for any investment losses. Please invest only what you can afford to lose and always conduct your own research (DYOR) before making any investment decisions.